Bridging Active Heroin Users to Hepatitis C Treatment Using Buprenorphine - 1

• Status: Completed
• Trial end date: 2006-06-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to see whether street-recruited heroin users can be successfully treated for hepatitis C after stabilizing them on buprenorphine.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Institute on Drug Abuse (NIDA)
• Collaborator: Organization to Achieve Solutions in Substance Abuse (OASIS)
• Treatments: Buprenorphine; Buprenorphine, Naloxone Drug Combination; Naloxone

Criteria

Inclusion Criteria:

• Active heroin or other illicit opioid use

• Active hepatitis C

• No medical or psychiatric contraindications

• Able to sign informed consent

Exclusion Criteria:

• No opiate dependence

• Age <18

• Unable or uninterested in attending weekly group sessions